Company profile: Plasma-Therm
1.1 - Company Overview
Company description
- Provider of etch and thin film deposition equipment and configurable wafer processing platforms for global compound semiconductor and related specialty markets. Offerings include plasma etch, thin film deposition, rapid thermal processing, plasma dicing, die singulation, and Tegal Diode RIE systems. U.S.-based, with over 35 years enabling process technologies and 24 patents in plasma process.
Products and services
- Plasma Etch Systems: Plasma-based equipment used in semiconductor manufacturing to precisely remove material patterns during etching steps for device fabrication, supporting compound semiconductor and specialty markets
- Thin Film Deposition Systems: Thin-film tools for depositing uniform layers on semiconductor wafers, enabling material creation and stack formation for microelectronics manufacturing across compound semiconductor applications
- Configurable Wafer Processing Platforms: Configurable systems architected for standard and advanced microelectronics processes, including etch, deposition, material modification, and die singulation, integrating multiple wafer processing capabilities
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Plasma-Therm
Bruker Alicona
HQ: Austria
Website
- Description: Provider of optical 3D surface measurement technology for quality assurance in laboratories and production. Offers optical 3D metrology and Focus-Variation technology for non-contact, high-resolution 3D measurements, bridging coordinate metrology and surface roughness measurement. Products include µCMM, InfiniteFocus G6, InfiniteFocusSL, and Real3DUnitX to measure dimensions, position, shape, and roughness of complex components.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bruker Alicona company profile →
Magnetic Insight
HQ: United States
Website
- Description: Provider of preclinical magnetic particle imaging solutions for cellular imaging to measure cancer immunotherapy efficacy, including Momentum CT, an MPI imager with integrated X-ray/CT for high sensitivity and resolution in vivo imaging; VivoTrax and VivoTrax Plus tracers for cell, vascular and lymph node imaging; Relax software to predict nanoparticle imaging behavior; and MagImage for 2D/3D visualization, co-registration, and advanced data analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Magnetic Insight company profile →
Anasys Instruments
HQ: United States
Website
- Description: Provider of nanoscale infrared spectroscopy and thermal measurement instruments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anasys Instruments company profile →
Hysitron
HQ: United States
Website
- Description: Provider of nanomechanical test instrumentation, developing, manufacturing, selling, and servicing cutting-edge instruments for the scientific community, featuring in-situ imaging with nanomechanical property measurement capabilities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hysitron company profile →
N4 Pharma
HQ: United Kingdom
Website
- Description: Provider of drug reformulation solutions, developing and out-licensing new versions of existing and novel high-value drugs for unmet needs. Advances products to clinical proof of concept then partners for regulatory. Offerings include Nuvec, a silica nanoparticle system to protect and deliver siRNA, RNA, and DNA; LipTide, a lipid and peptide-based platform that mimics a natural virus for targeted RNA delivery; and ECP105, an siRNA therapy for post-surgical glaucoma by silencing MRTF-B.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full N4 Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Plasma-Therm
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Plasma-Therm
2.2 - Growth funds investing in similar companies to Plasma-Therm
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Plasma-Therm
4.2 - Public trading comparable groups for Plasma-Therm
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →